. Kinesin-1 negative control for the continuous titration assay, related to Figure  2 . Plot of rKin430-GFP intensity on the microtubules against the protein concentration in solution during titration of rKin430-GFP into the microscope chamber. The paclitaxel-MTs (blue) were plotted separately from the GMPCPP MTs (red). Error bars represent the SEM (n = 10). The GFP intensity showed a linear response. Table 1 . Plots of mutant DCX-GFP intensity on the microtubules against the protein concentration in solution during titration of the protein into the microscope chamber. Both paclitaxel-and GMPCPP-microtubules were present in the microscope chamber. In cases where a bright subset of the paclitaxel-microtubules emerged (e.g., panel L, R192W), the bright subset was plotted in blue and the dim subset was plotted together with the GMPCPPmicrotubules in red. In cases where no bright subset emerged, the paclitaxel-microtubules were plotted in blue and the GMPCPP-microtubules were plotted in red. The panels are: A nucleation reaction produces an initially-heterogeneous population of microtubules (left, pink and blue microtubules). DCX specifically stabilizes the 13-pf fraction over the others; the non-13-pf fractions undergo catastrophes and, over time, the population evolves toward homogeneity (right, blue microtubules). (B) Interaction with Polymerization Intermediates. A nucleation reaction produces small oligomers of tubulin (i) at early time points. DCX interacts with these oligomeric species such that a homogeneous population of 13-pf microtubules emerges (right, blue microtubules). Alternatively, DCX interacts with microtubule end structures (ii) such that the end structures evolve into a 13-pf lattice.
SUPPLEMENTAL EXPERIMENTAL PROCEDURES

Expression and Purification of DCX, related constructs, and control proteins
We induced expression of DCX-GFP in the BL21(DE3) strain of E. coli at OD(600) = 0.6 with 0.5 mM IPTG for 14 h at 18 °C. Cells were harvested by centrifugation, resuspended in 50 mM Na 2 HPO 4 , 300 mM NaCl, 10 mM imidazole, 10% glycerol and lysed using a French press in the presence of a protease inhibitor cocktail. Bacterial lysates were clarified by centrifugation. The cleared lysate was loaded onto a Ni-NTA affinity column (1 ml HisTrap HP, GE Healthcare) and eluted using a continuous imidazole gradient from 0 to 250 mM on an FPLC system (Akta Purifier, GE Healthcare). Peak fractions were loaded onto a 1 ml Strep-Tactin Superflow gravity flow column (IBA, Germany), which bound the C-terminal Strep-tag II. Purified DCX was eluted with desthiobiotin following manufacturer's protocols. Optionally, Strep-Tactin-bound protein was incubated overnight with PreScission protease before elution, which cleaved the poly-His tag. The protein was used fresh and/or aliquots were flash frozen in LN 2 in the presence of 10% glycerol and stored in elution buffer. Protein concentration and purity were determined using SDS-PAGE and absorbance at 280 nm and 488 nm using a NanoDrop spectrophotometer (Thermo Scientific).
Total-Internal-Reflection Fluorescence Microscopy
The microscope setup uses a Zeiss Axiovert Z1 microscope chassis, 100x 1.45 NA Plan-apochromat objective lens, and the Zeiss TIRF III slider. Diode-pumped solid-state lasers (Cobolt Jive, Cobolt Calypso) were coupled to fiber-optic cables in free space and introduced into the Zeiss slider. Images were recorded using an Andor iXon+ DV-897 EMCCD camera. Microscope chambers were constructed using custom-machined mounts diagrammed in Gell et al. (2010) . In brief, microscope cover glass were silanized as described (Helenius et al., 2006) . A 22x22 mm glass and an 18x18 mm glass were separated by double-sided tape, such that a narrow channel was created for the exchange of solution. Images were acquired using Metamorph. Simple measurements of microtubule intensities were made using the Linescan feature in Metamorph, and all intensity values are reported as mean ± SD. The absolute values of intensity are a function of laser power, laser alignment, and camera gain.
Tubulin and Microtubule Preparations
(1) Microtubule polymerization in the presence of GTP followed by stabilization with paclitaxel (paclitaxel-MTs, mixed-pf number): A polymerization mixture was prepared with BRB80 + 32 µM tubulin + 1 mM GTP + 4 mM MgCl 2 + 5% DMSO. The mixture was incubated on ice for 5 min, followed by incubation at 37 °C for 30 min. The polymerized microtubules were diluted into prewarmed BRB80 + 10 µM paclitaxel, centrifuged at maximum speed in a Beckman Airfuge, and resuspended in BRB80 + 10 µM paclitaxel. (2) Microtubule Polymerization in the presence of GMPCPP (14-pf): A polymerization mixture was prepared with BRB80 + 2 µM tubulin, 1 mM GMPCPP (Jena Biosciences), and 1 mM MgCl 2 . The mixture was incubated on ice for 5 min, followed by incubation at 37 °C for 2 hours. The polymerized GMPCPP microtubules were centrifuged at maximum speed in a Beckman Airfuge and resuspended in BRB80. (3) Comparison of Microtubule polymerized from Axonemes (13-pf) with GMPCPP microtubules (14-pf): Sea urchin sperm axonemes were a generous gift from Dr. Ted Salmon (University of North Carolina at Chapel Hill). The purified axoneme stock was diluted 1:4000 in BRB80 and introduced into a microscope chamber together with an anti-TAMRA antibody (1:200, Invitrogen). The axonemes adhered non-specifically to the cover glass surface. The chamber was rinsed with BRB80, followed by a 5 min incubation with BRB80 + 1% Pluronic F-127, followed by a rinse with BRB80. At this point, the chamber was placed onto the microscope with the objective heater set to 35 °C. Polymerization buffer was then introduced: BRB80 + 12 µM Alexa-546 tubulin, 1 mM GTP, 1 mM MgCl 2 , 0.1 mg/ml bovine serum albumin (BSA). Microtubules were grown from the axonemes for 10 min, at which point the microscope chamber was rinsed with BRB80 + 10 µM paclitaxel, which stabilized the axonemal microtubules, and an image was taken to record the location of the axonemal microtubules. TAMRA-labeled GMPCPP microtubules were diluted into BRB80 + paclitaxel and introduced into the flow chamber. The GMPCPP microtubules bound to the chamber surfaces via the anti-TAMRA antibody, creating a microscope chamber containing both axonemal microtubules and GMPCPP microtubules. A solution of 0.5 µM DCX-GFP was prepared in imaging buffer: BRB80 + 10 µM paclitaxel + 0.1 mg/ml BSA + antifade reagents (Gell et al., 2010) ; this solution was introduced into the microscope chamber and images were recorded. (4) Comparison of mixedpf Microtubules and GMPCPP microtubules (14-pf): Microtubules were prepared as described in (1) and (2) above, with the modification that either the GTP + paclitaxel microtubules or the GMPCPP microtubules were prepared with a lower ratio of fluorescently-labeled tubulin, creating, for example, bright GMPCPP-MTs and dim paclitaxel-MTs. Both types of microtubules were adhered to the surface of the microscope chamber using anti-TAMRA antibodies as described (Gell et al., 2010) . This microtubule preparation was the default condition for the majority of experiments described in this manuscript, as the GMPCPP microtubules served as a consistent internal control for the behavior of the paclitaxel-MT population.
